FREDRIC N ESHELMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FREDRIC N ESHELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDRIC N ESHELMAN. FREDRIC N ESHELMAN is Director in Valeant Pharmaceuticals International, Inc. ($BVF) and CEO in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Chief Executive Officer in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in MEDICINES CO /DE ($MDCO) and Executive Chairman in MEDICINES CO /DE ($MDCO) and Director in Aravive, Inc. ($ARAV) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in EYENOVIA, INC. ($EYEN).
Latest Insider Trading Transactions of FREDRIC N ESHELMAN
Sentiment: All, ARAV, BVF, EYEN, GTHX, MDCO, PPDI
Page: < prev 1 2 3 4 5 6 7 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.04 | 1,533 | 53,716 | 8,829,994 | 8.8 M to 8.8 M (-0.02 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.03 | 100 | 3,503 | 8,831,527 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.01 | 400 | 14,004 | 8,831,627 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.00 | 1,300 | 45,500 | 8,832,027 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.99 | 1,100 | 38,489 | 8,833,327 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.98 | 1,100 | 38,478 | 8,834,427 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.97 | 500 | 17,485 | 8,835,527 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.96 | 1,100 | 38,456 | 8,836,027 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.95 | 1,664 | 58,157 | 8,837,127 | 8.8 M to 8.8 M (-0.02 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.94 | 1,230 | 42,976 | 8,838,791 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.93 | 906 | 31,647 | 8,840,021 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.92 | 1,105 | 38,587 | 8,840,927 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.91 | 1,095 | 38,226 | 8,842,032 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.90 | 1,000 | 34,900 | 8,843,127 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.89 | 1,291 | 45,043 | 8,844,127 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.88 | 809 | 28,218 | 8,845,418 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.87 | 200 | 6,974 | 8,846,227 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.86 | 305 | 10,632 | 8,846,427 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.85 | 195 | 6,796 | 8,846,732 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.84 | 300 | 10,452 | 8,846,927 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.83 | 900 | 31,347 | 8,847,227 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.82 | 200 | 6,964 | 8,848,127 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.81 | 200 | 6,962 | 8,848,327 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.80 | 100 | 3,480 | 8,848,527 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.78 | 400 | 13,912 | 8,848,627 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.76 | 100 | 3,476 | 8,849,027 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.71 | 100 | 3,471 | 8,849,127 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.67 | 100 | 3,467 | 8,849,227 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.66 | 400 | 13,864 | 8,849,327 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.65 | 400 | 13,860 | 8,849,727 | 8.9 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.64 | 400 | 13,856 | 8,850,127 | 8.9 M to 8.9 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.63 | 100 | 3,463 | 8,850,527 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.90 | 600 | 20,940 | 8,850,627 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.89 | 100 | 3,489 | 8,851,227 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.87 | 433 | 15,099 | 8,851,327 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.86 | 400 | 13,944 | 8,851,760 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.85 | 1,000 | 34,850 | 8,852,160 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.84 | 1,900 | 66,196 | 8,853,160 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.83 | 1,100 | 38,313 | 8,855,060 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.82 | 1,100 | 38,302 | 8,856,160 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.81 | 2,100 | 73,101 | 8,857,260 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.80 | 1,800 | 62,640 | 8,859,360 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.79 | 2,600 | 90,454 | 8,861,160 | 8.9 M to 8.9 M (-0.03 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.78 | 200 | 6,956 | 8,863,760 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.76 | 800 | 27,808 | 8,863,960 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.75 | 2,453 | 85,242 | 8,864,760 | 8.9 M to 8.9 M (-0.03 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.74 | 3,901 | 135,521 | 8,867,213 | 8.9 M to 8.9 M (-0.04 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.73 | 746 | 25,909 | 8,871,114 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.72 | 200 | 6,944 | 8,871,860 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.71 | 100 | 3,471 | 8,872,060 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.69 | 3,200 | 111,008 | 8,872,160 | 8.9 M to 8.9 M (-0.04 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.68 | 2,400 | 83,232 | 8,875,360 | 8.9 M to 8.9 M (-0.03 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.67 | 2,600 | 90,142 | 8,877,760 | 8.9 M to 8.9 M (-0.03 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.66 | 4,000 | 138,640 | 8,880,360 | 8.9 M to 8.9 M (-0.05 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.65 | 2,500 | 86,625 | 8,884,360 | 8.9 M to 8.9 M (-0.03 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.64 | 200 | 6,928 | 8,886,860 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.63 | 200 | 6,926 | 8,887,060 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.62 | 300 | 10,386 | 8,887,260 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.61 | 4,300 | 148,823 | 8,887,560 | 8.9 M to 8.9 M (-0.05 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.60 | 1,400 | 48,440 | 8,891,860 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.59 | 4,500 | 155,655 | 8,893,260 | 8.9 M to 8.9 M (-0.05 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.58 | 1,900 | 65,702 | 8,897,760 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.57 | 200 | 6,914 | 8,899,660 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.55 | 100 | 3,455 | 8,899,860 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.54 | 1,400 | 48,356 | 8,899,960 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.53 | 1,100 | 37,983 | 8,901,360 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.52 | 200 | 6,904 | 8,902,460 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.51 | 200 | 6,902 | 8,902,660 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.50 | 600 | 20,700 | 8,902,860 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.49 | 200 | 6,898 | 8,903,460 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.48 | 600 | 20,688 | 8,903,660 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.45 | 200 | 6,890 | 8,904,260 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.44 | 100 | 3,444 | 8,904,460 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.43 | 100 | 3,443 | 8,904,560 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.42 | 100 | 3,442 | 8,904,660 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.41 | 500 | 17,205 | 8,904,760 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.40 | 1,000 | 34,400 | 8,905,260 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.39 | 1,700 | 58,463 | 8,906,260 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.38 | 1,200 | 41,256 | 8,907,960 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.37 | 600 | 20,622 | 8,909,160 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.36 | 400 | 13,744 | 8,909,760 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.35 | 500 | 17,175 | 8,910,160 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.34 | 600 | 20,604 | 8,910,660 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.33 | 400 | 13,732 | 8,911,260 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.32 | 200 | 6,864 | 8,911,660 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.31 | 600 | 20,586 | 8,911,860 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.30 | 200 | 6,860 | 8,912,460 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.29 | 500 | 17,145 | 8,912,660 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.28 | 400 | 13,712 | 8,913,160 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.27 | 400 | 13,708 | 8,913,560 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.26 | 200 | 6,852 | 8,913,960 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.25 | 600 | 20,550 | 8,914,160 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.24 | 2,100 | 71,904 | 8,914,760 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.23 | 400 | 13,692 | 8,916,860 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.22 | 900 | 30,798 | 8,917,260 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.21 | 200 | 6,842 | 8,918,160 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.20 | 900 | 30,780 | 8,918,360 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.19 | 200 | 6,838 | 8,919,260 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.18 | 100 | 3,418 | 8,919,460 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.17 | 300 | 10,251 | 8,919,560 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.16 | 1,100 | 37,576 | 8,919,860 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.15 | 500 | 17,075 | 8,920,960 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.14 | 3,100 | 105,834 | 8,921,460 | 8.9 M to 8.9 M (-0.03 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.13 | 4,800 | 163,824 | 8,924,560 | 8.9 M to 8.9 M (-0.05 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.12 | 1,600 | 54,592 | 8,929,360 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.11 | 1,000 | 34,110 | 8,930,960 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.10 | 600 | 20,460 | 8,931,960 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.09 | 800 | 27,272 | 8,932,560 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.08 | 100 | 3,408 | 8,933,360 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.07 | 400 | 13,628 | 8,933,460 | 8.9 M to 8.9 M (0.00 %) |
| Apr 18 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.05 | 100 | 3,405 | 8,933,860 | 8.9 M to 8.9 M (0.00 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.74 | 200 | 6,748 | 8,933,960 | 8.9 M to 8.9 M (0.00 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.70 | 200 | 6,740 | 8,934,160 | 8.9 M to 8.9 M (0.00 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.69 | 933 | 31,433 | 8,934,360 | 8.9 M to 8.9 M (-0.01 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.68 | 2,195 | 73,928 | 8,935,293 | 8.9 M to 8.9 M (-0.02 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.67 | 2,618 | 88,148 | 8,937,488 | 8.9 M to 8.9 M (-0.03 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.66 | 6,707 | 225,758 | 8,940,106 | 8.9 M to 8.9 M (-0.07 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.65 | 3,980 | 133,927 | 8,946,813 | 9 M to 8.9 M (-0.04 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.64 | 4,772 | 160,530 | 8,950,793 | 9 M to 9 M (-0.05 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.63 | 4,100 | 137,883 | 8,955,565 | 9 M to 9 M (-0.05 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.62 | 5,619 | 188,911 | 8,959,665 | 9 M to 9 M (-0.06 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.61 | 1,909 | 64,161 | 8,965,284 | 9 M to 9 M (-0.02 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.60 | 7,300 | 245,280 | 8,967,193 | 9 M to 9 M (-0.08 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.59 | 7,200 | 241,848 | 8,974,493 | 9 M to 9 M (-0.08 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.58 | 6,017 | 202,051 | 8,981,693 | 9 M to 9 M (-0.07 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.57 | 3,683 | 123,638 | 8,987,710 | 9 M to 9 M (-0.04 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.56 | 3,811 | 127,897 | 8,991,393 | 9 M to 9 M (-0.04 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.55 | 7,390 | 247,935 | 8,995,204 | 9 M to 9 M (-0.08 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.54 | 3,100 | 103,974 | 9,002,594 | 9 M to 9 M (-0.03 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.53 | 5,199 | 174,322 | 9,005,694 | 9 M to 9 M (-0.06 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.52 | 4,208 | 141,052 | 9,010,893 | 9 M to 9 M (-0.05 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.51 | 1,092 | 36,593 | 9,015,101 | 9 M to 9 M (-0.01 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.50 | 200 | 6,700 | 9,016,193 | 9 M to 9 M (0.00 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.49 | 300 | 10,047 | 9,016,393 | 9 M to 9 M (0.00 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.48 | 100 | 3,348 | 9,016,693 | 9 M to 9 M (0.00 %) |
| Apr 03 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.40 | 500 | 16,700 | 9,016,793 | 9 M to 9 M (-0.01 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.79 | 900 | 28,611 | 9,017,593 | 9 M to 9 M (-0.01 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.78 | 2,182 | 69,344 | 9,018,493 | 9 M to 9 M (-0.02 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.77 | 5,018 | 159,422 | 9,020,675 | 9 M to 9 M (-0.06 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.76 | 5,199 | 165,120 | 9,025,693 | 9 M to 9 M (-0.06 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.75 | 6,801 | 215,932 | 9,030,892 | 9 M to 9 M (-0.08 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.74 | 1,000 | 31,740 | 9,037,693 | 9 M to 9 M (-0.01 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.73 | 2,334 | 74,058 | 9,038,693 | 9 M to 9 M (-0.03 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.72 | 2,000 | 63,440 | 9,041,027 | 9 M to 9 M (-0.02 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.71 | 900 | 28,539 | 9,043,027 | 9 M to 9 M (-0.01 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.70 | 4,500 | 142,650 | 9,043,927 | 9 M to 9 M (-0.05 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.69 | 1,500 | 47,535 | 9,048,427 | 9 M to 9 M (-0.02 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.68 | 3,213 | 101,788 | 9,049,927 | 9.1 M to 9 M (-0.04 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.67 | 4,687 | 148,437 | 9,053,140 | 9.1 M to 9.1 M (-0.05 %) |
| Mar 20 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.66 | 4,166 | 131,896 | 9,057,827 | 9.1 M to 9.1 M (-0.05 %) |